U.S. markets open in 8 hours 44 minutes
  • S&P Futures

    3,616.25
    -20.25 (-0.56%)
     
  • Dow Futures

    29,676.00
    -198.00 (-0.66%)
     
  • Nasdaq Futures

    12,228.50
    -29.00 (-0.24%)
     
  • Russell 2000 Futures

    1,838.20
    -14.80 (-0.80%)
     
  • Crude Oil

    44.80
    -0.73 (-1.60%)
     
  • Gold

    1,772.80
    -15.30 (-0.86%)
     
  • Silver

    22.12
    -0.51 (-2.27%)
     
  • EUR/USD

    1.1976
    +0.0006 (+0.05%)
     
  • 10-Yr Bond

    0.8420
    0.0000 (0.00%)
     
  • Vix

    20.84
    -0.41 (-1.93%)
     
  • GBP/USD

    1.3343
    +0.0029 (+0.21%)
     
  • USD/JPY

    103.8520
    -0.2330 (-0.22%)
     
  • BTC-USD

    18,539.82
    +6.94 (+0.04%)
     
  • CMC Crypto 200

    365.50
    +28.00 (+8.30%)
     
  • FTSE 100

    6,367.58
    +4.65 (+0.07%)
     
  • Nikkei 225

    26,432.51
    -212.20 (-0.80%)
     

CORRECTED-Regeneron says its COVID-19 antibody treatment cut medical visits in trial

(Corrects trial size)

Oct 28 (Reuters) - Regeneron Pharmaceuticals Inc said on Wednesday that its COVID-19 antibody cocktail - the experimental treatment that U.S. President Donald Trump received - significantly reduced medical visits in a trial of around 800 patients with mild-to-moderate sickness.

The company said it has shared the results with the U.S. Food and Drug Administration as part of its review of the company's request for emergency use authorization of the treatment. (Reporting by Michael Erman; Editing by Leslie Adler)